The primary objective of Sirtex is to research, develop and commercialise effective treatments for liver cancer using novel small particle technology. Liver cancer is a disease of the cell. It develops when cells in a part of the body begin to grow out of control. Cancer cells can form a mass of tissue commonly referred to as a tumour.
Sirtex has developed an innovative means of treating liver cancer. In cases where it is not possible to surgically remove the liver tumours, this product can be used to deliver targeted, internal irradiation therapy directly to the tumour. This new therapy is called Selective Internal Radiation Therapy also know as SIRT.
On the day of your treatment, you will be asked to arrive approximately two hours before the procedure is scheduled. Staff will assist you in completing paperwork, inquire about your medical history and any allergies you may have, and may start an IV containing anti-nausea medication and a mild steroid to reduce possible side effects.
Routine lab work is performed prior to moving you to the appropriate angiography suite where the procedure will be performed. You should not eat or drink for a specified time the night before your procedure.
Purchase orders need to be completed and faxed to 1-978-229-9585 or emailed to firstname.lastname@example.org no later than Tuesday afternoon of the week before the treatment. In order for Sirtex to be able to ship doses to a hospital, the centre needs to have a Sirtex-approved radioactive materials license which lists SIR-Spheres microspheres or a comparable statement as authorized by the respective state.
In addition, hospital contact information must be kept current. Please visit the Starting a SIR-Spheres Program section for more information. Treatment days of the week are: Tuesday, Wednesday, and Thursday. Doses are delivered on the day of scheduled administration. Dose availability may be affected by holidays.